Journal
JOURNAL OF CROHNS & COLITIS
Volume 14, Issue -, Pages S807-S814Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ecco-jcc/jjaa125
Keywords
Pregnancy; inflammatory bowel disease; COVID-19; SARS-CoV2
Categories
Funding
- ECCO
- IOIBD
Ask authors/readers for more resources
The rapid emergence of the novel coronavirus [SARS-CoV2] and the coronavirus disease 2019 [COVID-19] has caused significant global morbidity and mortality. This is particularly concerning for vulnerable groups such as pregnant women with inflammatory bowel disease [IBD]. Care for pregnant IBD patients in itself is a complex issue because of the delicate balance between controlling maternal IBD as well as promoting the health of the unborn child. This often requires continued immunosuppressive maintenance medication or the introduction of new IBD medication during pregnancy. The current global COVID-19 pandemic creates an additional challenge in the management of pregnant IBD patients. In this paper we aimed to answer relevant questions that can be encountered in daily clinical practice when caring for pregnant women with IBD during the current COVID-19 pandemic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available